active substance: piracetam, cinnarizine. 1 capsule contains: piracetam 400 mg, cinnarizine 25 mg;
excipients: lactose monohydrate, colloidal anhydrous silicon dioxide, magnesium stearate; hard gelatin capsules: gelatin, titanium dioxide (E 171).
Adults. Maintenance therapy for symptoms of cerebrovascular origin, including impaired memory and thinking functions, mood (irritability), poor concentration.
Maintenance therapy for symptoms of labyrinthine disorders including vertigo, tinnitus, nystagmus, nausea, vomiting; with Meniere’s syndrome.
Prevention of motion sickness.
Children. Treatment of dyslexia in children older than 8 years in conjunction with other appropriate methods, including speech therapy.
Dosage & Administration
Neuro-Norm capsules are administered orally after meals, not liquid, squeezed water.
Adults. Disorders of cerebral circulation: 1 capsule 3 times a day.
Imbalance: 1 capsule 3 times a day.
Diseases of movement: adults 1 capsule half hour before walking with a repetition every 6 hours.
Children. In the complex treatment of dyslexia Neuro-Norm is used in children older than 8 years vozras: 1-2 capsules 1-2 times a day depending on the severity of the disease.
The course of treatment – 1-3 months. Do not use for longer than 3 months. Perhaps a 2-3 courses per year.
Hypersensitivity to piracetam, cinnarizine or any subsidiary component of the drug; individual sensitivity to derivatives pirolidona.
Severe renal insufficiency, acute ischemic stroke (hemorrhagic stroke), Huntington’s chorea, Parkinson’s disease, increased intraocular pressure, agitation.
During pregnancy and breastfeeding.
Children under 8 years old.